News

Have you ever gone on strike?

How can we combat compassion fatigue by practicing what we preach?

How can telehealth help academic psychiatry departments improve administrative efficiency and expand their clinical services?

Sticks and stones may break my bones, but words can never hurt me…

The endocrine system is an important puzzle piece when addressing psychiatric disorders.

How do you screen for childhood trauma? One doctor at the 2022 Annual Psychiatric Times™ World CME Conference in San Diego, one doctor shared his most helpful tips.

Despite mixed data, there are some psychopharmacological options for treating PTSD.

What are some of the most exciting emerging and established methods?

What are the key differences?

Here's why more research is important to help us better understand the effects of cannabis on our patients.

How can we, as clinicians, understand how trauma has affected our patients and respond in the most effective way?

Is it prolonged grief or MDD? Expert shares insights at premiere annual meeting.

Are you forgetting something?

What is the model minority myth and how is it harming us all?

This summer issue of Psychiatric Times is heating up. Don't miss a single clinical pearl!

“Build it, and he will come.”

Psychiatric Times Diversity and Inclusion Editor shares insights on the arts, humanity, and peace.

Considering challenges and opportunities in digital health solutions for mental health care.

We have an urgent need for new and improved treatment options for depression—are psychedelic medications the answer?

Is the term, "extrapyramidal symptoms," an example of a “4-letter word”?

Further evidence-based antidepressant treatments are needed for children and adolescents with depression.

A Little League World Series player just showed the world what sportsmanship should look like.

“The mentality that animates workers who see their work as a calling is strikingly simple: They believe their work is contributing to the construction of a world within which they would like to live.”

Thomas Insel, MD’s, book contains several highly valuable lessons for psychiatry and beyond.

Cannabis use disorder and nonadherence: How can we best educate patients?

An estimated 5% to 10% of acute psychiatric inpatients have catatonia—yet catatonia remains widely underdiagnosed.

Alzheimer disease psychosis treatment pimavanserin receives Complete Response Letter from the FDA.

Psychiatry is in the woods…

What is the mindset of “anti-vaxxers,” and how can you connect with them as a clinician?

This novel schizophrenia treatment showed positive results in a phase 3 trial evaluating efficacy, safety, and tolerability.